Coercive ControlCCVCSNCT07578194
Coercive Control and Intimate Partner Violence
A study testing questionnaire in people with Coercive Control, run by Centre Hospitalier Intercommunal Robert Ballanger at 1 site in France.
Trial summary
Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly… Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Coercive Control
- What is being tested?
- questionnaire
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 250 participants
- Where
- 1 siteFrance
- Study dates
- 30 May 2026to 30 May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
- Women identified as victims of intimate partner violence.
- Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
- No objection to participation in the study (non-opposition).
- Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).
Who cannot join
- Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
- Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
- Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
CHI Robert Ballanger
Aulnay-sous-Bois, Île-de-France Region, 93600
Nour BEKOUCHE, Head manager, 0033141708631, nour.bekouche@ght-gpne.fr
Fatima Le Griguer, psychologist
About this study
Official title: Coercive Control and Intimate Partner Violence: Examining the Relationships Between Exposure to Violence and Victims' Physical and Mental Health Outcomes
Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care.
The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.
- Conditions
- Coercive Control
- Being tested
- questionnaire
- Keywords
- partner violence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnaireOther
Participants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment
| Study group | Role | What they receive |
|---|---|---|
| Questionnaire arm | Experimental | Participants will complete online questionnaires via the Qualtrics platform Receives: Other: questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Coercive Control Screening Scale
Measure of Coercive Control Screening Scale (CCSS). Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
Measured: Measure of CCSS between inlusion and month 6
Secondary outcomes (8)
Measure of Hospital Anxiety and Depression scale (HAD scale)
correlation between HAD scale and CCSS scale. Minimal scale = 0, maximal scale = 42. Higher score means worse outcome
Measured: Measure of HHAD scale between inclusion and month 6
Severity of post-traumatic stress disorder symptoms
Severity of post-traumatic stress disorder (PTSD) symptoms assessed by the PTSD Checklist for DSM-5 (PCL-5), based on total score and DSM-5 clinical thresholds. Minimal scale = 0, maximal scale = 80. Higher score means worse outcome
Measured: at inclusion and month 6
International Trauma Questionnaire (ITQ).
International Trauma Questionnaire (ITQ), according to ICD-11 criteria. Minimal scale = 0, maximal scale = 72. Higher score means worse outcome
Measured: Inclusion and month 6
Severity of emotional dysregulation
Severity of emotional dysregulation assessed using the Difficulties in Emotion Regulation Scale - French version (DERS-F). Minimal scale = 36, maximal scale = 180. Higher score means worse outcome
Measured: inclusion and month 6
Short Form Health Survey (SF-12)
Health-related quality of life assessed using the 12-Item Short Form Health Survey (SF-12), including physical and mental component summary scores. optimal scale more than 40. scale < 40 means worse outcome
Measured: inclusion and month 6
Brief Pain Inventory
Pain intensity and functional impact assessed using the Brief Pain Inventory (BPI). mninimal scale = 0, maximal scale = 10. Higher score means worse outcome
Measured: at inclusion and month 6
Coercive Control Scale (CCSS)
Analysis of score distribution on the Coercive Control Scale (CCSS) to determine a clinically relevant threshold for coercive control. Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
Measured: inclusion and month 6
Woman Abuse Screening Tool (WAST)
Intimate partner violence assessed using the Woman Abuse Screening Tool (WAST). minimal scale = 0, maximal scale = 16. Higher score means worse outcome
Measured: inclusion and month 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 May 2026
- Study start30 May 2026 (estimated)
- Primary completion30 May 2028 (estimated)
- Study completion30 May 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Coercive ControlStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Intercommunal Robert Ballanger
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- fatima F Le Griguer, psychologist, Principal investigator, CHI Robert Balanger of GHT GPNE
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07578194
- Sponsor's protocol ID
- GHT GPNE
- Acronym
- CCVCS
- Status last verified
- May 2026
- First submitted
- 5 May 2026
- Last updated
- 26 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Coercive Control and Intimate Partner Violence: Examining the Relationships Between Exposure to Violence and Victims' Physical and Mental Health Outcomes
- ClinicalTrials.gov ID
- NCT07578194
- Acronym / sponsor ID
- CCVCS / GHT GPNE
- Conditions
- Coercive Control
- Keywords
- partner violence
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Centre Hospitalier Intercommunal Robert BallangerUniversity, hospital or other
- Study start
- 30 May 2026 (estimated)
- Primary completion
- 30 May 2028 (estimated)
- Study completion
- 30 May 2028 (estimated)
- First posted
- 11 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care.
The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Questionnaire arm | Experimental | Other: questionnaireParticipants will complete online questionnaires via the Qualtrics platform |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
- Women identified as victims of intimate partner violence.
- Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
- No objection to participation in the study (non-opposition).
- Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).
Key exclusion criteria (3 listed)
- Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
- Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
- Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnaireParticipants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment | Other | Questionnaire arm |
Primary outcome
Coercive Control Screening Scale
Time frame: Measure of CCSS between inlusion and month 6
Measure of Coercive Control Screening Scale (CCSS). Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
8 secondary outcomes
Measure of Hospital Anxiety and Depression scale (HAD scale)
Time frame: Measure of HHAD scale between inclusion and month 6
Severity of post-traumatic stress disorder symptoms
Time frame: at inclusion and month 6
International Trauma Questionnaire (ITQ).
Time frame: Inclusion and month 6
Severity of emotional dysregulation
Time frame: inclusion and month 6
Short Form Health Survey (SF-12)
Time frame: inclusion and month 6
Brief Pain Inventory
Time frame: at inclusion and month 6
Coercive Control Scale (CCSS)
Time frame: inclusion and month 6
Woman Abuse Screening Tool (WAST)
Time frame: inclusion and month 6
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
fatima F Le Griguer, psychologist principal investigator
CHI Robert Balanger of GHT GPNE
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing questionnaire in people with Coercive Control, run by Centre Hospitalier Intercommunal Robert Ballanger at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Fatima F LE GRIGUER, Principal Investigator (00 33 1 49 36 72 38, fatima.le-griguer@ght-gpne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Coercive Control Screening Scale (time frame: Measure of CCSS between inlusion and month 6). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.